1. Home
  2. NICE Guidance
  3. Published Guidance

Omalizumab for previously treated chronic spontaneous urticaria

Technology appraisal guidance [TA339] Published: 08 June 2015

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Review decision  
  • Review decision - July 2018  
  • Review decision paper PDF 467 KB 12 July 2018  
  • Matrix of stakeholders PDF 216 KB 12 July 2018